Phosphodiesterase type III inhibitor, cilostazol, inhibits colon cancer cell motility
Kohei Murata(Suita Municipal Hospital), Shingi Imaoka(Osaka International Cancer Institute), Hiroaki Ohigashi(Teine Keijinkai Hospital), Tadanori Mammoto(Medical College of Wisconsin), Mutsuko Mukai(Institute of Cytochemistry and Molecular Pharmacology), Yo Sasaki(SHOWA Medical University), Masahiro Hiratsuka(Osaka International Cancer Institute), Hitoshi Akedo(Hyogo Medical University), Masao Kameyama, Fumiyo Fukui(Osaka Hospital), T Kabuto, Osamu Ishikawa(Gunma University)
Cited by 35
Related Papers
Increased Nuclear NAD Biosynthesis and SIRT1 Activation Prevent Axonal Degeneration
|Science|2004|1.1k
AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1
|Nature Genetics|2000|950
Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice
|Cell Metabolism|2016|900
Nampt/PBEF/Visfatin Regulates Insulin Secretion in β Cells as a Systemic NAD Biosynthetic Enzyme
|Cell Metabolism|2007|899
Mechanical control of tissue and organ development
|Development|2010|855